Malignant melanoma and cdkn2a
This presentation is the property of its rightful owner.
Sponsored Links
1 / 47

Malignant Melanoma and CDKN2A PowerPoint PPT Presentation


  • 138 Views
  • Uploaded on
  • Presentation posted in: General

Malignant Melanoma and CDKN2A. Kate Coffin. http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg. Melanoma. Genetics and Environment Skin cancer of melanocytes Pre-existing nevus or new nevus Different areas of skin ABCDE assessment system of skin.

Download Presentation

Malignant Melanoma and CDKN2A

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Malignant melanoma and cdkn2a

Malignant Melanoma and CDKN2A

Kate Coffin

http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg


Melanoma

Melanoma

Genetics and Environment

Skin cancer of melanocytes

Pre-existing nevus or new nevus

Different areas of skin

ABCDE assessment system of skin

http://www.aad.org/skin-conditions/dermatology-a-to-z/melanoma/signs-symptoms/melanoma-signs-and-symptoms


Dangers of melanoma

Dangers of Melanoma

Leading cause of death due to skin disease

2012 estimates in US

76,250 new cases

9,180 deaths

National Cancer Institute

http://www.cancer.gov/cancertopics/types/melanoma

http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots


Metastasis

Metastasis

Spreading to other areas of skin and other tissues

14% 5 year survival rate

Miller, A et al. (2006). Melanoma. The New England Journal of Medicine. 355(1), 51-65. PMID:16822996


Cdkn2a cyclin dependent kinase inhibitor 2a

CDKN2A Cyclin-dependent kinase inhibitor 2A

Inhibits CDK4

Tumor Suppressor

>30 germline mutations

http://en.wikipedia.org/wiki/File:Protein_CDKN2A_PDB_1a5e.png


Cdkn2a domains ankyrin repeats

CDKN2A Domains – Ankyrin repeats

Pfam

SMART

Found in archaea, bacteria, eukarya, and poxvirues

In other proteins associated with human disease

http://smart.embl-heidelberg.de/

http://pfam.sanger.ac.uk/


Cdkn2a gene ontology

CDKN2A Gene Ontology

Biological Processes

- cell cycle arrest- cell cycle checkpoint

- induction of apoptosis- negative regulation of cell growth

Cellular Components

- nucleus- cytoplasm

Molecular Functions

-cyclin-dependent kinase inhibitor

- protein kinase binding

http://amigo.geneontology.org/cgi-bin/amigo/go.cgi


Cdkn2a protein phylogeny

CDKN2A Protein Phylogeny

http://www.ebi.ac.uk/Tools/msa/clustalw2/


Human cdkn2a interaction network

Human CDKN2A Interaction Network

http://string-db.org/


Human cdkn2a interaction network1

Human CDKN2A Interaction Network

http://string-db.org/


Human cdkn2a interaction network2

Human CDKN2A Interaction Network

http://string-db.org/


Human cdk4 interaction network

Human CDK4 Interaction Network

http://string-db.org/


Cdk4 domains protein kinase

CDK4 Domains – Protein Kinase

Pfam

Conserved from E. coli to humans

Catalytic component of Serine/Threoninekinases

http://pfam.sanger.ac.uk/


Cdk4 gene ontology

CDK4 Gene Ontology

Biological Processes

- regulation of cell cycle- regulation of cell proliferation

- signal transduction

Cellular Components

- cyclin-dependent protein kinaseholoenzyme complex

- transcription factor complex

Molecular Functions

-cyclin-dependent protein kinase activity

- ATP binding

http://amigo.geneontology.org/cgi-bin/amigo/go.cgi


Model of cdkn2a and cdk4

Model of CDKN2A and CDK4

CDK4

CDKN2A


Model of cdkn2a and cdk41

Model of CDKN2A and CDK4

CDK4

CDKN2A

Regulated Growth

http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg


Model of cdkn2a and cdk42

Model of CDKN2A and CDK4

CDK4

CDKN2A


Model of cdkn2a and cdk43

Model of CDKN2A and CDK4

CDK4

CDKN2A

Unregulated

Growth

http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/250px-Melanoma.jpg


Model of cdkn2a and cdk44

Model of CDKN2A and CDK4

?

CDK4

CDKN2A


Model of cdkn2a and cdk45

Model of CDKN2A and CDK4

?

CDK4

CDKN2A

Regulated Growth

http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg


Question

Question

Can I find a compound that mimics

CDKN2A by inhibiting CDK4?


Question1

Question

Can I find a compound that mimics

CDKN2A by inhibiting CDK4?

Hypothesis

If a compound were known to interact with and inhibit CDK4, it could be used as a drug for melanoma


Experiment identify compound

Experiment – Identify Compound

http://pubchem.ncbi.nlm.nih.gov/


Results identify compound

Results – Identify Compound

2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione

Cdk4 Inhibitor III

http://pubchem.ncbi.nlm.nih.gov/


Results identify compound1

Results – Identify Compound

http://pubchem.ncbi.nlm.nih.gov/


Question2

Question

Can I find a compound that mimics

CDKN2A by inhibiting CDK4?

Hypothesis

If a compound were known to interact with and inhibit CDK4, it could be used as a drug for melanoma

Hypothesis

If Cdk4 were inhibited by Cdk4 Inhibitor III in a Cdkn2a CKO mouse, the tumor cells would not proliferate and metastasize


Why choose a mouse

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg


Why choose a mouse1

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpg


Why choose a mouse2

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

http://string-db.org/


Experiment treatment groups

Experiment – Treatment Groups

1

Cdkn2a +/+

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg


Experiment treatment groups1

Experiment – Treatment Groups

1

Cdkn2a +/+

2

Cdkn2a -/- (CKO)

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg


Experiment treatment groups2

Experiment – Treatment Groups

1

Cdkn2a +/+

2

Cdkn2a -/- (CKO)

3

Cdkn2a +/+

& Cdk4 Inhibitor III

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg


Experiment treatment groups3

Experiment – Treatment Groups

1

Cdkn2a +/+

Cdkn2a -/- (CKO)

2

3

Cdkn2a +/+

& Cdk4 Inhibitor III

4

Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg


Experiment graft human melanoma

Experiment – Graft Human Melanoma

Cdkn2a +/+

Cdkn2a -/- (CKO)

1

2

Cdkn2a +/+

& Cdk4 Inhibitor III

Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

3

4

https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpg

http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg


Data collection

Data Collection

Microarray analysis of

Cdkn2a and Cdk4

expression in cells of mice

https://commons.wikimedia.org/wiki/File:DNA_microarray.svg


Expected microarray results

Expected Microarray Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4


Expected microarray results1

Expected Microarray Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4


Expected microarray results2

Expected Microarray Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4


Expected microarray results3

Expected Microarray Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4


Expected microarray results4

Expected Microarray Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4


Expected metastasis results

Expected Metastasis Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III


Expected metastasis results1

Expected Metastasis Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

LEAST METASTASIS


Expected metastasis results2

Expected Metastasis Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

MOST METASTASIS

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

LEAST METASTASIS


Expected metastasis results3

Expected Metastasis Results

1) Cdkn2a +/+

2) Cdkn2a -/- (CKO)

MODERATE METASTASIS

MOST METASTASIS

3) Cdkn2a +/+

& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)

& Cdk4 Inhibitor III

MODERATE METASTASIS

LEAST METASTASIS


Conclusion

Conclusion

CDK4 Inhibitor III could be used as an antimelanoma drug by mimicking the tumor suppressor function of CDKN2A in patients with CDKN2A loss of function mutations


Future directions

Future Directions

Test other modes of drug administration

Topical cream vs Intravenous solution

Different dosages/times of administration

Study other proteins in interaction network

Look for other tumor suppressors

Study effects of UV exposure on CDKN2A

How does SPF affect this interaction?

Look for compounds in other mutated melanoma pathways


Questions

Questions?

http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg


  • Login